# US 2021/0277044 A1 · Novel molecules for targeting ribosomes and ribosome-interacting proteins, and uses thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0277044 A1
- Document ID: US20210277044A1
- Status: Published application
- Kind: A1
- Application number: 17/259,088
- Filed: 2019-07-08
- Published: 2021-09-09
- Earliest claimed: 2018-07-10
- Assignees: Immagina Biotechnology S.r.l.
- Applicants: Immagina Biotechnology S.r.l.
- Inventors: Massimiliano CLAMER; Luca MINATI
- Web page: https://patentgrep.com/patent/US20210277044A1

## CPC

- C07H 19/16: Purine radicals
- C07D 473/34: attached in position 6, e.g. adenine
- C07H 19/167: with ribosyl as the saccharide radical
- G01N 33/68: involving proteins, peptides or amino acids {(involving lipoproteins G01N33/92)}
- G01N 33/6848: {Methods of protein analysis involving mass spectrometry}
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

Molecule having the structural formula (I): (I) for use as targeting probe of translating ribosomes and ribosome-interacting proteins.

## Claims

### Claim at position 1

1-11. (canceled)

### Claim 12

A chemical compound having the structural formula (I):
wherein
R1 and R2 are independently selected from
L is selected from
T is selected from
with the proviso that
if R1 is
then R2 is

### Claim 13 (depends on 12)

The chemical compound according to claim 12, wherein R1 is
R2 is selected from
and
L is

### Claim 14 (depends on 13)

The chemical compound according to claim 13, wherein T is

### Claim 15 (depends on 12)

The chemical compound according to claim 12, wherein R1 and R2 are
and
L is selected from

### Claim 16 (depends on 15)

The chemical compound according to claim 15, wherein
L is
and T is

### Claim 17 (depends on 15)

The chemical compound according to claim 15, wherein L is
and T is

### Claim 18 (depends on 12)

A method for targeting a translating ribosome, a ribosome-interacting protein, or a protein associated to a nascent polypeptide emerging, during its translation, from a ribosome in a biological sample comprising the following steps: (i) putting in contact a chemical compound of claim 12 with the biological sample, (ii) exposing the biological sample and the chemical compound to UV irradiation so that the chemical compound binds to the translating ribosome, the ribosome-interacting protein or the protein associated to a nascent polypeptide emerging from the ribosome forming a complex, and (iii) detecting the chemical compound bound to the translating ribosome, the ribosome-interacting protein or the protein associated to a nascent polypeptide emerging from the ribosome.

### Claim 19 (depends on 18)

The method according to claim 18, wherein before step (iii) a purification step of the complex from the biological sample is carried out.

### Claim 20 (depends on 19)

The method according to claim 19, wherein the purification step of the complex is carried out by separating the complex from the biological sample by means of coupling the complex with a bead, wherein the bead includes an azide moiety bound to its surface able to react with the alkyne group present in the chemical compound.

### Claim 21 (depends on 19)

The method according to claim 19, wherein the purification step of a complex comprising the translating ribosome associated to an RNA and the chemical compound is carried out by means of RNA extraction followed by coupling the RNA bound to the chemical compound with a bead, wherein the bead includes an azide moiety bound to its surface able to react with the alkyne group present in the chemical compound.

### Claim 22 (depends on 18)

The method according to claim 18, wherein the detection step (iii) is carried out by means of immunoblot, mass-spectroscopy, RNA sequencing or detection of light emission from a fluorescent molecule comprising an azide moiety able to react with the alkyne group present in the chemical compound or a luminescent molecule binding a biotin molecule comprising an azide moiety able to react with the alkyne group present in the chemical compound.

### Claim 23 (depends on 22)

The method according to claim 22, wherein the immunoblot is carried out by means of an anti-puromycin antibody.

### Claim 24 (depends on 18)

The method according to claim 18, comprising a further step (iv) of identification of the ribosome-associated RNA, the ribosome-associated protein, the ribosome-interacting protein or the protein associated to a nascent polypeptide emerging from the ribosome bound with the chemical compound.

### Claim 25 (depends on 24)

The method according to claim 24, wherein the identification is carried out by means of immunoblot, mass-spectroscopy, or RNA sequencing.

### Claim 26 (depends on 18)

The method according to claim 18, wherein the biological sample is selected from a cell culture, a cell lysate and a tissue lysate.

### Claim 27 (depends on 18)

The method according to claim 18, wherein the translating ribosome is associated to an RNA, or a protein.

### Claim 28 (depends on 18)

The method according to claim 18, wherein the ribosome interacting protein is selected from the following families: elongation factors, chaperon proteins, ribosomal proteins, proteins involved in cell metabolism, RNA processing proteins, proteins part of cytoskeleton.

### Claim 29 (depends on 27)

The method according to claim 27, wherein the ribosome-associated RNA is selected from rRNA, non-coding RNA and mRNA.

### Claim 30 (depends on 12)

A process of monitoring protein synthesis comprising labelling a translating ribosome, a ribosome-interacting protein, or a protein associated to a nascent polypeptide emerging, during its translation, from a ribosome in a biological sample with a chemical compound of claim 12.

### Claim 31 (depends on 12, 30)

The process of claim 30, wherein the labelling comprises UV irradiation of the chemical compound of claim 12 to form a covalent link between the chemical compound of claim 12 and the translating ribosome, ribosome-interacting protein, or protein associated to the nascent polypeptide.

### Claim 32 (depends on 30)

The process of claim 30, further comprising detecting the labeled translating ribosome, ribosome-interacting protein, or protein associated to the nascent polypeptide.

### Claim 33 (depends on 30)

The process of claim 30, further comprising separating the labeled translating ribosome, ribosome-interacting protein, or protein associated to the nascent polypeptide.

### Claim 34 (depends on 33)

The process of claim 33, wherein the separating comprises coupling the labeled translating ribosome, ribosome-interacting protein, or protein associated to the nascent polypeptide with a reporter tag through an alkyne azide reaction.

### Claim 35 (depends on 34)

The process of claim 34, further comprising detecting the labeled translating ribosome, ribosome-interacting protein, or protein associated to the nascent polypeptide that has the reporter tag.

### Claim 36 (depends on 30)

The process of claim 30, further comprising identifying the labeled translating ribosome, ribosome-interacting protein, or protein associated to the nascent polypeptide.

### Claim 37 (depends on 30)

The process of claim 30, wherein the translating ribosome is associated with an RNA or a protein.
